Home » Life & Medical » Research on Patient Derived Xenograft Models Market 2016-2020 and Forecast 2021-2026

Research on Patient Derived Xenograft Models Market 2016-2020 and Forecast 2021-2026

  76 Pages     Life & Medical  

Available Formats      

Report ID: 67419
Published By: 99Strategy

Summary

The Global Patient Derived Xenograft Models market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Patient Derived Xenograft Models by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Mice Models 

Rat Models

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Crown Bioscience Inc. (US) 

WuXi AppTec (China) 

Champions Oncology, Inc. (US) 

The Jackson Laboratory (US) 

ONCODESIGN (France) 

Charles River Laboratories International, Inc. (US) 

EPO Berlin-Buch GmBH (Germany) 

Shanghai LIDE Biotech Co., Ltd (China) 

Xentech (France) 

Horizon Discovery Group PLC (UK) 

Urolead (France) 

Explora BioLabs (US)

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Pharmaceutical & Biotechnology Companies 

Contract Research Organizations 

Academic & Research Institutions

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

1 Industry Overview

1.1 Patient Derived Xenograft Models Industry

Figure Patient Derived Xenograft Models Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Patient Derived Xenograft Models

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Patient Derived Xenograft Models

1.2.2 Downstream

Table Application Segment of Patient Derived Xenograft Models

Table Global Patient Derived Xenograft Models Market 2016-2026, by Application, in USD Million

1.2.3 COVID-19 Impact

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Patient Derived Xenograft Models Market by Type

3.1 By Type

3.1.1 Mice Models 

Table Major Company List of Mice Models 

3.1.2 Rat Models

Table Major Company List of Rat Models

3.2 Market Size

Table Global Patient Derived Xenograft Models Market 2016-2020, by Type, in USD Million

Figure Global Patient Derived Xenograft Models Market Growth 2016-2020, by Type, in USD Million

Table Global Patient Derived Xenograft Models Market 2016-2020, by Type, in Volume

Figure Global Patient Derived Xenograft Models Market Growth 2016-2020, by Type, in Volume

3.3 Market Forecast

Table Global Patient Derived Xenograft Models Market Forecast 2021-2026, by Type, in USD Million

Table Global Patient Derived Xenograft Models Market Forecast 2021-2026, by Type, in Volume

4 Major Companies List

4.1 Crown Bioscience Inc. (US)  (Company Profile, Sales Data etc.)

4.1.1 Crown Bioscience Inc. (US)  Profile

Table Crown Bioscience Inc. (US)  Overview List

4.1.2 Crown Bioscience Inc. (US)  Products & Services

4.1.3 Crown Bioscience Inc. (US)  Business Operation Conditions

Table Business Operation of Crown Bioscience Inc. (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 WuXi AppTec (China)  (Company Profile, Sales Data etc.)

4.2.1 WuXi AppTec (China)  Profile

Table WuXi AppTec (China)  Overview List

4.2.2 WuXi AppTec (China)  Products & Services

4.2.3 WuXi AppTec (China)  Business Operation Conditions

Table Business Operation of WuXi AppTec (China)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 Champions Oncology, Inc. (US)  (Company Profile, Sales Data etc.)

4.3.1 Champions Oncology, Inc. (US)  Profile

Table Champions Oncology, Inc. (US)  Overview List

4.3.2 Champions Oncology, Inc. (US)  Products & Services

4.3.3 Champions Oncology, Inc. (US)  Business Operation Conditions

Table Business Operation of Champions Oncology, Inc. (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 The Jackson Laboratory (US)  (Company Profile, Sales Data etc.)

4.4.1 The Jackson Laboratory (US)  Profile

Table The Jackson Laboratory (US)  Overview List

4.4.2 The Jackson Laboratory (US)  Products & Services

4.4.3 The Jackson Laboratory (US)  Business Operation Conditions

Table Business Operation of The Jackson Laboratory (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 ONCODESIGN (France)  (Company Profile, Sales Data etc.)

4.5.1 ONCODESIGN (France)  Profile

Table ONCODESIGN (France)  Overview List

4.5.2 ONCODESIGN (France)  Products & Services

4.5.3 ONCODESIGN (France)  Business Operation Conditions

Table Business Operation of ONCODESIGN (France)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 Charles River Laboratories International, Inc. (US)  (Company Profile, Sales Data etc.)

4.6.1 Charles River Laboratories International, Inc. (US)  Profile

Table Charles River Laboratories International, Inc. (US)  Overview List

4.6.2 Charles River Laboratories International, Inc. (US)  Products & Services

4.6.3 Charles River Laboratories International, Inc. (US)  Business Operation Conditions

Table Business Operation of Charles River Laboratories International, Inc. (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 EPO Berlin-Buch GmBH (Germany)  (Company Profile, Sales Data etc.)

4.7.1 EPO Berlin-Buch GmBH (Germany)  Profile

Table EPO Berlin-Buch GmBH (Germany)  Overview List

4.7.2 EPO Berlin-Buch GmBH (Germany)  Products & Services

4.7.3 EPO Berlin-Buch GmBH (Germany)  Business Operation Conditions

Table Business Operation of EPO Berlin-Buch GmBH (Germany)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.8 Shanghai LIDE Biotech Co., Ltd (China)  (Company Profile, Sales Data etc.)

4.8.1 Shanghai LIDE Biotech Co., Ltd (China)  Profile

Table Shanghai LIDE Biotech Co., Ltd (China)  Overview List

4.8.2 Shanghai LIDE Biotech Co., Ltd (China)  Products & Services

4.8.3 Shanghai LIDE Biotech Co., Ltd (China)  Business Operation Conditions

Table Business Operation of Shanghai LIDE Biotech Co., Ltd (China)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.9 Xentech (France)  (Company Profile, Sales Data etc.)

4.9.1 Xentech (France)  Profile

Table Xentech (France)  Overview List

4.9.2 Xentech (France)  Products & Services

4.9.3 Xentech (France)  Business Operation Conditions

Table Business Operation of Xentech (France)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.10 Horizon Discovery Group PLC (UK)  (Company Profile, Sales Data etc.)

4.10.1 Horizon Discovery Group PLC (UK)  Profile

Table Horizon Discovery Group PLC (UK)  Overview List

4.10.2 Horizon Discovery Group PLC (UK)  Products & Services

4.10.3 Horizon Discovery Group PLC (UK)  Business Operation Conditions

Table Business Operation of Horizon Discovery Group PLC (UK)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.11 Urolead (France)  (Company Profile, Sales Data etc.)

4.11.1 Urolead (France)  Profile

Table Urolead (France)  Overview List

4.11.2 Urolead (France)  Products & Services

4.11.3 Urolead (France)  Business Operation Conditions

Table Business Operation of Urolead (France)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.12 Explora BioLabs (US) (Company Profile, Sales Data etc.)

4.12.1 Explora BioLabs (US) Profile

Table Explora BioLabs (US) Overview List

4.12.2 Explora BioLabs (US) Products & Services

4.12.3 Explora BioLabs (US) Business Operation Conditions

Table Business Operation of Explora BioLabs (US) (Sales Revenue, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Patient Derived Xenograft Models Sales Revenue 2016-2020, by Company, in USD Million

Table Global Patient Derived Xenograft Models Sales Revenue Share 2016-2020, by Company, in USD Million

Figure Global Patient Derived Xenograft Models Sales Revenue Share in 2020, by Company, in USD Million

Table Global Patient Derived Xenograft Models Sales Volume 2016-2020, by Company, in Volume

Table Global Patient Derived Xenograft Models Sales Volume Share 2016-2020, by Company, in Volume

Figure Global Patient Derived Xenograft Models Sales Volume Share in 2020, by Company, in Volume

5.2 Regional Market by Company

Figure North America Patient Derived Xenograft Models Market Concentration, in 2020

Figure Europe Patient Derived Xenograft Models Market Market Concentration, in 2020

Figure Asia-Pacific Patient Derived Xenograft Models MMarket Concentration, in 2020

Figure South America Patient Derived Xenograft Models Market Concentration, in 2020

Figure Middle East & Africa Patient Derived Xenograft Models Market Concentration, in 2020

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Pharmaceutical & Biotechnology Companies 

Figure Patient Derived Xenograft Models Demand in Pharmaceutical & Biotechnology Companies , 2016-2020, in USD Million

Figure Patient Derived Xenograft Models Demand in Pharmaceutical & Biotechnology Companies , 2016-2020, in Volume

6.1.2 Demand in Contract Research Organizations 

Figure Patient Derived Xenograft Models Demand in Contract Research Organizations , 2016-2020, in USD Million

Figure Patient Derived Xenograft Models Demand in Contract Research Organizations , 2016-2020, in Volume

6.1.3 Demand in Academic & Research Institutions

Figure Patient Derived Xenograft Models Demand in Academic & Research Institutions, 2016-2020, in USD Million

Figure Patient Derived Xenograft Models Demand in Academic & Research Institutions, 2016-2020, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Patient Derived Xenograft Models Demand Forecast 2021-2026, by Application, in USD Million

Figure Patient Derived Xenograft Models Market Growth 2021-2026, by Application, in USD Million

Figure Patient Derived Xenograft Models Market Share in 2026, by Application, in USD Million

Table Patient Derived Xenograft Models Demand Forecast 2021-2026, by Application, in Volume

Table Patient Derived Xenograft Models Market Growth 2021-2026, by Application, in Volume

Table Patient Derived Xenograft Models Market Share in 2026, by Application, in Volume

6.4 Impact of the COVID-19 on the Demand

7 Region Operation

7.1 Regional Production

Table Patient Derived Xenograft Models Production 2016-2020, by Region, in USD Million

Table Patient Derived Xenograft Models Production 2016-2020, by Region, in Volume

7.2 Regional Market

Table Global Patient Derived Xenograft Models Market 2016-2020, by Region, in USD Million

Table Global Patient Derived Xenograft Models Market Share 2016-2020, by Region, in USD Million

Table Global Patient Derived Xenograft Models Market 2016-2020, by Region, in Volume

Table Global Patient Derived Xenograft Models Market Share 2016-2020, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million

Figure North America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million

Table North America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million

Figure Europe Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million

Table Europe Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million

Figure Asia-Pacific Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million

Table Asia-Pacific Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million

Figure South America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million

Table South America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million

Figure Middle East & Africa Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million

Table Middle East & Africa Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Patient Derived Xenograft Models Market Forecast 2021-2026, by Region, in USD Million

Table Patient Derived Xenograft Models Market Forecast 2021-2026, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

1. Table Upstream Segment of Patient Derived Xenograft Models

2. Table Application Segment of Patient Derived Xenograft Models

3. Table Global Patient Derived Xenograft Models Market 2016-2026, by Application, in USD Million

4. Table Major Company List of Rat Models

5. Table Global Patient Derived Xenograft Models Market 2016-2020, by Type, in USD Million

6. Table Global Patient Derived Xenograft Models Market 2016-2020, by Type, in Volume

7. Table Global Patient Derived Xenograft Models Market Forecast 2021-2026, by Type, in USD Million

8. Table Global Patient Derived Xenograft Models Market Forecast 2021-2026, by Type, in Volume

9. Table Crown Bioscience Inc. (US)  Overview List

10. Table Business Operation of Crown Bioscience Inc. (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

11. Table WuXi AppTec (China)  Overview List

12. Table Business Operation of WuXi AppTec (China)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

13. Table Champions Oncology, Inc. (US)  Overview List

14. Table Business Operation of Champions Oncology, Inc. (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

15. Table The Jackson Laboratory (US)  Overview List

16. Table Business Operation of The Jackson Laboratory (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

17. Table ONCODESIGN (France)  Overview List

18. Table Business Operation of ONCODESIGN (France)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

19. Table Charles River Laboratories International, Inc. (US)  Overview List

20. Table Business Operation of Charles River Laboratories International, Inc. (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

21. Table EPO Berlin-Buch GmBH (Germany)  Overview List

22. Table Business Operation of EPO Berlin-Buch GmBH (Germany)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

23. Table Shanghai LIDE Biotech Co., Ltd (China)  Overview List

24. Table Business Operation of Shanghai LIDE Biotech Co., Ltd (China)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

25. Table Xentech (France)  Overview List

26. Table Business Operation of Xentech (France)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

27. Table Horizon Discovery Group PLC (UK)  Overview List

28. Table Business Operation of Horizon Discovery Group PLC (UK)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

29. Table Urolead (France)  Overview List

30. Table Business Operation of Urolead (France)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

31. Table Explora BioLabs (US) Overview List

32. Table Business Operation of Explora BioLabs (US) (Sales Revenue, Cost, Gross Margin)

33. Table Global Patient Derived Xenograft Models Sales Revenue 2016-2020, by Company, in USD Million

34. Table Global Patient Derived Xenograft Models Sales Revenue Share 2016-2020, by Company, in USD Million

35. Table Global Patient Derived Xenograft Models Sales Volume 2016-2020, by Company, in Volume

36. Table Global Patient Derived Xenograft Models Sales Volume Share 2016-2020, by Company, in Volume

37. Table Regional Demand Comparison List

38. Table Major Application in Different Regions

39. Table Patient Derived Xenograft Models Demand Forecast 2021-2026, by Application, in USD Million

40. Table Patient Derived Xenograft Models Demand Forecast 2021-2026, by Application, in Volume

41. Table Patient Derived Xenograft Models Market Growth 2021-2026, by Application, in Volume

42. Table Patient Derived Xenograft Models Market Share in 2026, by Application, in Volume

43. Table Patient Derived Xenograft Models Production 2016-2020, by Region, in USD Million

44. Table Patient Derived Xenograft Models Production 2016-2020, by Region, in Volume

45. Table Global Patient Derived Xenograft Models Market 2016-2020, by Region, in USD Million

46. Table Global Patient Derived Xenograft Models Market Share 2016-2020, by Region, in USD Million

47. Table Global Patient Derived Xenograft Models Market 2016-2020, by Region, in Volume

48. Table Global Patient Derived Xenograft Models Market Share 2016-2020, by Region, in Volume

49. Table North America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million

50. Table North America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume

51. Table Europe Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million

52. Table Europe Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume

53. Table Asia-Pacific Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million

54. Table Asia-Pacific Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume

55. Table South America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million

56. Table South America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume

57. Table Middle East & Africa Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million

58. Table Middle East & Africa Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume

59. Table Patient Derived Xenograft Models Market Forecast 2021-2026, by Region, in USD Million

60. Table Patient Derived Xenograft Models Market Forecast 2021-2026, by Region, in Volume

61. Table Price Factors List

List of Figure

1. Figure Patient Derived Xenograft Models Industry Chain Structure

2. Figure Global Patient Derived Xenograft Models Market Growth 2016-2020, by Type, in USD Million

3. Figure Global Patient Derived Xenograft Models Market Growth 2016-2020, by Type, in Volume

4. Figure Global Patient Derived Xenograft Models Sales Revenue Share in 2020, by Company, in USD Million

5. Figure Global Patient Derived Xenograft Models Sales Volume Share in 2020, by Company, in Volume

6. Figure North America Patient Derived Xenograft Models Market Concentration, in 2020

7. Figure Europe Patient Derived Xenograft Models Market Market Concentration, in 2020

8. Figure Asia-Pacific Patient Derived Xenograft Models MMarket Concentration, in 2020

9. Figure South America Patient Derived Xenograft Models Market Concentration, in 2020

10. Figure Middle East & Africa Patient Derived Xenograft Models Market Concentration, in 2020

11. Figure Patient Derived Xenograft Models Demand in Pharmaceutical & Biotechnology Companies , 2016-2020, in USD Million

12. Figure Patient Derived Xenograft Models Demand in Pharmaceutical & Biotechnology Companies , 2016-2020, in Volume

13. Figure Patient Derived Xenograft Models Demand in Contract Research Organizations , 2016-2020, in USD Million

14. Figure Patient Derived Xenograft Models Demand in Contract Research Organizations , 2016-2020, in Volume

15. Figure Patient Derived Xenograft Models Demand in Academic & Research Institutions, 2016-2020, in USD Million

16. Figure Patient Derived Xenograft Models Demand in Academic & Research Institutions, 2016-2020, in Volume

17. Figure Patient Derived Xenograft Models Market Growth 2021-2026, by Application, in USD Million

18. Figure Patient Derived Xenograft Models Market Share in 2026, by Application, in USD Million

19. Figure North America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million

20. Figure North America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume

21. Figure Europe Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million

22. Figure Europe Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume

23. Figure Asia-Pacific Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million

24. Figure Asia-Pacific Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume

25. Figure South America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million

26. Figure South America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume

27. Figure Middle East & Africa Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million

28. Figure Middle East & Africa Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume

29. Figure Marketing Channels Overview

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Courant.Biz | Powered By SAIME DIGITAL TECHNOLOGIES PVT. LTD. | © 2020